Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer

Journal of Clinical Pathology

Volumn 56, Issue 8, 2003, Pages 569-574

  Pillai, M R ^a   Chacko, P ^a   Kesari, L A ^a   Jayaprakash, P G ^a   Jayaram, H N ^c   Antony, A C ^b,c  

^a REGIONAL CANCER CENTRE   (India)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; FOLATE RECEPTOR; NUCLEAR RIBONUCLEOPROTEIN E1; RECEPTOR; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; FEMALE; HETEROLOGOUS EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDIATOR; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; WART VIRUS;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL TRANSFORMATION, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CHI-SQUARE DISTRIBUTION; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; REPRESSOR PROTEINS; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0041589490     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.8.569     Document Type: Article

References (38)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. IntJ Cancer 1999;80:827-41.
2. Berumen J, Ordonez RM, Lazcano E, et al. Asian-American variants of human papillomavirus 16 and risk for cervical concer: a case-control study. J Natl Cancer Inst 2001 ;93:1325-30.
3. Shanta V, Krishnamurthi S, Gajalakshmi CK, et al. Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc 2000;98:49-52.
4. Suris JC, Dexeus S. Survival in cervical cancer. Eur J Gynaecol Oncol 1998;19:11-13.
5. Bosch FX, Munoz N, Meijer CJ M, et al. The causal relation between human papillomavirus and cervical cancer [review]. J Clin Pathol 2002;55:244-65.
6. Johnston C. Quantitative tests for human papillomavirus [editorial]. Lancet 2000;355:2179-80.
7. Burk RD. Pernicious papillomavirus infection [editorial]. N EnglJ Med 1999;341:1687-8.
8. Collier B, Goobar-Larsson L, Sokolowski M, eta/. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rCl-binding proteins 1 and 2. J Biol Chem 1998;273:22648-56.
9. Ylitalo N, Sorensen P, Josefsson AM, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2194-8.
10. Josefsson AM, Magnusson PKE, Ylitalo N, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2189-93.
11. Wallin K-L, Wiklund F, Angstrom T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-8.
12. Cox JT. Management of cervical intraepithelial neoplasia [editorial]. Lancet 1999;353:857-9.
13. Galloway DA. Is vaccination against human papillomavirus a possibility? Lancet 1998;351(suppl 3):22SIII-4SIII.
14. Bonn D, Bradbury J. The warts and all approach to tackling cervical cancer. Lancet 1998;351:810.
15. Antony AC. The biological chemistry of folate receptors. Blood 1992;79:2807-20.
16. Antony AC. Folate receptors. Annu Rev Nutr 1996;16:501-21.
17. Sun XL, Murphy BR, Li QJ, et al. Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo. J Clin Invest 1995;96:1535-47.
18. Wu M, Gunning W, Ratnam M. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomarkers Prev 1999;8:775-82.
19. Sun XL, Antony AC. Evidence that a specific interaction between an 18-base cis-element in the 5′-untranslated region of human folate receptor-alpha mRNA and a 46-kDa cytosolic trans-factor is critical for translation. J Biol Chem 1996;271:25539-47.
20. Xiao X, Tang Y-S, Mackins JY, et al. Isolation and characterization of a folate receptor mRNA-binding trans-factor from human placenta: evidence favoring identity with heterogeneous nuclear ribonucleoprotein E1. J Biol Chem 2001;276:41510-17.
21. Antony AC, Utley C, Van Horne KC, et al. Isolation and characterization of a folate receptor from human placenta. J Biol Chem 1981;256:9684-92.
22. Antony AC, Utley CS, Marcell PD, et al. Isolation, characterization, and comparison of the solubilized particulate and soluble folate binding proteins from human milk. J Biol Chem 1982;257:10081-9.
23. Antony AC, Bruno E, Briddell RA, et al. Effect of perturbation of specific folate receptors during in vitro erythropoiesis. J Clin Invest 1987;80:1618-23.
24. Verma RS, Gullapalli S, Antony AC. Evidence that the hydrophobicity of isolated, in situ, and de novo-synthesized native human placental folate receptors is a function of glycosyl-phosphatidylinositol anchoring to membranes. J Biol Chem 1992;267:4119-27.
25. Reddy J, Haneline L, Srour E, et al. Expression and functional characterization of the beta-isoform of the folate receptor on CD34+ cells. Blood 1999;93:3940-8.
26. Nair P, Jayaprakash PG, Nair MK, et al. Telomerase, p53 and human papillomavirus infection in the uterine cervix. Acta Oncol 2000;39:65-70.
27. Lakshmi S, Nair MB, Rajalakshmi TN, et al. Proliferating cell nuclear antigen expression and the progression of cervical intra epithelial neoplasia. Oncol Rep 1996;3:1195-8.
28. Pillai MR, Kesari AL, Chellam VG, et al. Spontaneous programmed cell death in infiltrating duct carcinoma: association with p53, BCL-2, hormone receptors and tumor proliferation. Pathol Res Pract 1998;194:549-57.
29. Nair P, Nair KM, Jayaprakash PG, Pillai MR. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection. Pathol Oncol Res 1999;5:95-103.
30. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia [see comments]. J Natl Cancer Inst 1993;85:958-64.
31. I Koutsky LP. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102(suppl 5A):3-8.
32. Ostareck-Lederer A, Ostareck DH, Hentze MW. Cytoplasmic regulatory functions of the KH-domain proteins hnRNPs K and E1/E2 [review]. Trends Biochem Sci 1998;23:409-471.
33. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [review]. Nucleic Acids Res 1997;25:3389-402.
34. McHugh M, Cheng YC. Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J Biol Chem 1979;254:11312-18.
35. Leamon CP, Low PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci U S A 1991;88:5572-6.
36. Leamon CP, Low PS. Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. Biochem J 1993;291(Pt 3):855-60.
37. Lu Y, Low PS. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol Immunother 2002;51:153-62.
38. Reddy JA, Low PS. Folate-mediated targeting of therapeutic and imaging agents to cancers [review]. Crit Rev Ther Drug Carrier Syst 1998;15:587-627.